Form 4 for CNMD CONMED Corp
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-25 · accession 0001127602-22-007085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-28 | 2022-02-25 | CNMD | Peters Stanley W III | VP GM Advanced Surgery | M - OptEx | $41.41 | +10.7K | 2,763 | New | +$443.1K |
| DM | 2022-02-28 | 2022-02-25 | CNMD | Peters Stanley W III | VP GM Advanced Surgery | S - Sale+OE | $148.42 | -10.7K | 63 | -99% | -$1.59M |
| DM | 2022-02-28 | 2022-02-25 | CNMD | Peters Stanley W III | VP GM Advanced Surgery | M - OptEx | $0.00 | -10.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-25 | M | A | 8,000 | $41.93 | 8,063 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-25 | S | D | 6,418 | $148.36 | 1,645 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.93. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Common | Common Stock | 2022-02-25 | S | D | 1,582 | $149.36 | 63 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $149.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 4 | Common | Common Stock | 2022-02-25 | M | A | 2,700 | $39.87 | 2,763 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-25 | S | D | 2,700 | $148.00 | 63 | D | — | — | |
| 6 | Derivative | Options To Purchase Common Stock | 2022-02-25 | M | D | 8,000 | $0.00 | 25,000 | D | $41.93 · — to 2027-03-01 | 8,000 Common Stock | (F3) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 7 | Derivative | Options To Purchase Common Stock | 2022-02-25 | M | D | 2,700 | $0.00 | 0 | D | $39.87 · — to 2026-03-01 | 2,700 Common Stock | (F3) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |